News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
COHEN RAYMOND W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 18,684 shares
@ $65.5409, valued at
$1.2M
Sold 22,052 shares
@ $66.2722, valued at
$1.5M
|
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 50,000 shares
@ $60, valued at
$3M
|
|
| 03/16/2022 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 17,787 shares
@ $50.4184, valued at
$896.8k
Sold 2,100 shares
@ $51.4001, valued at
$107.9k
Sold 1,981 shares
@ $52.6584, valued at
$104.3k
Sold 11,232 shares
@ $53.9533, valued at
$606k
Sold 16,900 shares
@ $54.7986, valued at
$926.1k
|
|
| 02/15/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 43,297 shares
@ $0
Sold 33,336 shares
@ $48.2103, valued at
$1.6M
Sold 1,779 shares
@ $49.0347, valued at
$87.2k
Granted 21,968 options to buy
@ $0
Granted 10,950 options to buy
@ $0
Exercised 42,500 options to buy
@ $0
Exercised 54,346 options to buy
@ $0 |
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 7,842 shares
@ $53.5766, valued at
$420.1k
Exercised 27,173 options to buy
@ $0 |
|
| 11/16/2020 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 5,625 shares
@ $32.45, valued at
$182.5k
|
|
| 10/07/2020 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 08/11/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 16,633 shares
@ $41.824, valued at
$695.7k
Sold 3,367 shares
@ $42.7455, valued at
$143.9k
Sold 5,159 shares
@ $40.9541, valued at
$211.3k
Sold 8,808 shares
@ $42.0534, valued at
$370.4k
Sold 11,033 shares
@ $42.776, valued at
$471.9k
|
|
| 07/17/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 8,628 shares
@ $38.5465, valued at
$332.6k
Sold 15,472 shares
@ $39.6073, valued at
$612.8k
Sold 900 shares
@ $39.9372, valued at
$35.9k
Sold 25,000 shares
@ $39.6507, valued at
$991.3k
|
|
| 07/15/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 24,800 shares
@ $40.3444, valued at
$1M
Sold 200 shares
@ $41.1, valued at
$8.2k
Sold 25,000 shares
@ $36.4909, valued at
$912.3k
|
|
| 03/18/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 34,269 shares
@ $20.8716, valued at
$715.2k
Sold 6,955 shares
@ $21.4795, valued at
$149.4k
Exercised 41,224 options to buy
@ $1.63, valued at
$67.2k
|
|
| 02/18/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 10,000 shares
@ $33.2065, valued at
$332.1k
Exercised 10,000 options to buy
@ $1.63, valued at
$16.3k
|
|
| 02/14/2020 |
5
| COHEN RAYMOND W (CEO) has filed a Form 5 on Axonics Modulation Technologies, Inc. |
| 02/03/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Exercised 16,667 options to buy
@ $0 |
|
| 01/16/2020 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 10,000 shares
@ $31.98, valued at
$319.8k
Exercised 10,000 options to buy
@ $1.63, valued at
$16.3k
|
|
| 12/16/2019 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 27,173 options to buy
@ $0
Granted 78,125 options to buy
@ $25.82, valued at
$2M
|
|
| 11/21/2019 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Sold 75,000 shares
@ $20.735, valued at
$1.6M
|
|
| 08/19/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 5,357 shares
@ $17.98, valued at
$96.3k
Exercised 5,357 options to buy
@ $1.12, valued at
$6k
|
|
| 08/06/2019 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Bought 3,500 shares
@ $30.4111, valued at
$106.4k
|
|
| 07/17/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 5,357 shares
@ $16.57, valued at
$88.8k
Exercised 5,357 options to buy
@ $1.12, valued at
$6k
|
|
| 06/21/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on SPECTRUM PHARMACEUTICALS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $8.44, valued at
$168.8k
|
|
| 06/19/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 5,357 shares
@ $17.48, valued at
$93.6k
Exercised 5,357 options to buy
@ $1.4, valued at
$7.5k
|
|
| 05/17/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 10,000 shares
@ $16.98, valued at
$169.8k
Sold 15,000 shares
@ $17.99, valued at
$269.9k
Exercised 10,000 options to buy
@ $1.9, valued at
$19k
|
|
| 04/19/2019 |
4
| COHEN RAYMOND W (Director) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Sold 15,000 shares
@ $17.03, valued at
$255.5k
Exercised 15,000 options to buy
@ $2.06, valued at
$30.9k
|
|
|
|
|